Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 2/2009, Volume 106, Issue 8, pp. 2933 - 2938
Oxidative stress has been implicated in the etiology of Parkinson's disease (PD) and in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model of...
Antioxidants | Oxidative stress | Special relativity | Astrocytes | Genes | Parkinson disease | Mice | Dosage | Response elements | Vehicles | Antioxidant response element | Human placental alkaline phosphatase | QUINONE REDUCTASE | OXIDATIVE STRESS | human placental alkaline phosphatase | LIPID-PEROXIDATION | MULTIDISCIPLINARY SCIENCES | IN-VIVO | HEME OXYGENASE-1 | SUBUNIT GENE | SUBSTANTIA-NIGRA | CEREBRAL-ISCHEMIA | antioxidant response element | INDUCIBLE EXPRESSION | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology | Immunohistochemistry | NF-E2-Related Factor 2 - physiology | Glial Fibrillary Acidic Protein - genetics | Parkinson Disease - pathology | Alkaline Phosphatase - genetics | Substantia Nigra - pathology | Astrocytes - pathology | MPTP Poisoning - physiopathology | Mice, Transgenic | DNA Primers | Parkinson Disease - physiopathology | Substantia Nigra - drug effects | Animals | Base Sequence | Corpus Striatum - drug effects | MPTP Poisoning - pathology | NF-E2-Related Factor 2 - genetics | Corpus Striatum - pathology | Disease Models, Animal | Prevention | Development and progression | Parkinson's disease | Health aspects | Index Medicus | Biological Sciences
Antioxidants | Oxidative stress | Special relativity | Astrocytes | Genes | Parkinson disease | Mice | Dosage | Response elements | Vehicles | Antioxidant response element | Human placental alkaline phosphatase | QUINONE REDUCTASE | OXIDATIVE STRESS | human placental alkaline phosphatase | LIPID-PEROXIDATION | MULTIDISCIPLINARY SCIENCES | IN-VIVO | HEME OXYGENASE-1 | SUBUNIT GENE | SUBSTANTIA-NIGRA | CEREBRAL-ISCHEMIA | antioxidant response element | INDUCIBLE EXPRESSION | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - pharmacology | Immunohistochemistry | NF-E2-Related Factor 2 - physiology | Glial Fibrillary Acidic Protein - genetics | Parkinson Disease - pathology | Alkaline Phosphatase - genetics | Substantia Nigra - pathology | Astrocytes - pathology | MPTP Poisoning - physiopathology | Mice, Transgenic | DNA Primers | Parkinson Disease - physiopathology | Substantia Nigra - drug effects | Animals | Base Sequence | Corpus Striatum - drug effects | MPTP Poisoning - pathology | NF-E2-Related Factor 2 - genetics | Corpus Striatum - pathology | Disease Models, Animal | Prevention | Development and progression | Parkinson's disease | Health aspects | Index Medicus | Biological Sciences
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2012, Volume 7, Issue 3, p. e33693
Background: Methylphenidate (MPH) is a psychostimulant that exerts its pharmacological effects via preferential blockade of the dopamine transporter (DAT) and...
EXTRACELLULAR DOPAMINE | ADHD | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | OXIDATIVE STRESS | REACTIVE OXYGEN | TYROSINE-HYDROXYLASE | MULTIDISCIPLINARY SCIENCES | NIGRA PARS COMPACTA | SUBSTANTIA-NIGRA | NEUROTOXICITY | PARKINSONS-DISEASE | Dopamine | RNA | Neurons | Genes | Smart drugs and nutrients | Attention-deficit hyperactivity disorder | Phenols | Narcolepsy | Methylphenidate hydrochloride | Gene expression | Methylphenidate | Attention deficit disorder | Oxidative stress | Neurosciences | Basal ganglia | Substantia nigra | Parkinsons disease | Neurobiology | Cognitive ability | Clinical trials | Interleukin 6 | Sleep disorders | Counting methods | Methamphetamines | Neostriatum | Dopamine transporter | Movement disorders | Dopamine receptors | Dosing | Glial cell line-derived neurotrophic factor | Holidays & special occasions | Attention deficit hyperactivity disorder | Central nervous system diseases | Exposure | Pharmacology | Inflammation | Norepinephrine transporter | Tumor necrosis factor-α | Ganglia | Children & youth | Microglia | Pathology | Brain research | Tumor necrosis factor | Cell number | College students | Norepinephrine | Mice | Cocaine | MPTP | Bayesian analysis | Transporter
EXTRACELLULAR DOPAMINE | ADHD | 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE | OXIDATIVE STRESS | REACTIVE OXYGEN | TYROSINE-HYDROXYLASE | MULTIDISCIPLINARY SCIENCES | NIGRA PARS COMPACTA | SUBSTANTIA-NIGRA | NEUROTOXICITY | PARKINSONS-DISEASE | Dopamine | RNA | Neurons | Genes | Smart drugs and nutrients | Attention-deficit hyperactivity disorder | Phenols | Narcolepsy | Methylphenidate hydrochloride | Gene expression | Methylphenidate | Attention deficit disorder | Oxidative stress | Neurosciences | Basal ganglia | Substantia nigra | Parkinsons disease | Neurobiology | Cognitive ability | Clinical trials | Interleukin 6 | Sleep disorders | Counting methods | Methamphetamines | Neostriatum | Dopamine transporter | Movement disorders | Dopamine receptors | Dosing | Glial cell line-derived neurotrophic factor | Holidays & special occasions | Attention deficit hyperactivity disorder | Central nervous system diseases | Exposure | Pharmacology | Inflammation | Norepinephrine transporter | Tumor necrosis factor-α | Ganglia | Children & youth | Microglia | Pathology | Brain research | Tumor necrosis factor | Cell number | College students | Norepinephrine | Mice | Cocaine | MPTP | Bayesian analysis | Transporter
Journal Article
Science, ISSN 0036-8075, 2014, Volume 344, Issue 6188, pp. 1178 - 1182
Auditory hallucinations in schizophrenia are alleviated by antipsychotic agents that inhibit D2 dopamine receptors (Drd2s). The defective neural circuits and...
MICE | HALLUCINATIONS | MULTIDISCIPLINARY SCIENCES | HYPOTHESIS | DIGEORGE-SYNDROME REGION | RNA-Binding Proteins - genetics | Thalamus - metabolism | Synaptic Transmission - genetics | Auditory Cortex - metabolism | MicroRNAs - metabolism | Receptors, Dopamine D2 - biosynthesis | Receptors, Dopamine D2 - genetics | 22q11 Deletion Syndrome - genetics | Haploinsufficiency | Drug Resistance - genetics | Animals | Schizophrenia - genetics | Antipsychotic Agents - therapeutic use | Mice, Mutant Strains | Mice | Schizophrenia - drug therapy | 22q11 Deletion Syndrome - drug therapy | Disease Models, Animal | Schizophrenia | Usage | Antipsychotic drugs | Research | Dopamine receptors | Neuropsychology | Sensory perception | Rodents | Information processing
MICE | HALLUCINATIONS | MULTIDISCIPLINARY SCIENCES | HYPOTHESIS | DIGEORGE-SYNDROME REGION | RNA-Binding Proteins - genetics | Thalamus - metabolism | Synaptic Transmission - genetics | Auditory Cortex - metabolism | MicroRNAs - metabolism | Receptors, Dopamine D2 - biosynthesis | Receptors, Dopamine D2 - genetics | 22q11 Deletion Syndrome - genetics | Haploinsufficiency | Drug Resistance - genetics | Animals | Schizophrenia - genetics | Antipsychotic Agents - therapeutic use | Mice, Mutant Strains | Mice | Schizophrenia - drug therapy | 22q11 Deletion Syndrome - drug therapy | Disease Models, Animal | Schizophrenia | Usage | Antipsychotic drugs | Research | Dopamine receptors | Neuropsychology | Sensory perception | Rodents | Information processing
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2014, Volume 9, Issue 3, p. e92422
Adenosine (ADO), a non-classical neurotransmitter and neuromodulator, and its metabolites adenosine triphosphate (ATP), adenosine diphosphate (ADP) and...
A(2A) RECEPTORS | ELECTROCHEMICAL DETECTION | ANTAGONISTIC INTERACTION | NERVE-TERMINALS | BASAL GANGLIA | MULTIDISCIPLINARY SCIENCES | ACETYLCHOLINE-RELEASE | RAT-BRAIN | PARKINSONS-DISEASE | NUCLEUS-ACCUMBENS | INDUCED SEIZURES | Adenosine Diphosphate - isolation & purification | Adenosine Triphosphate - isolation & purification | Adenosine Monophosphate - metabolism | Chromatography, High Pressure Liquid - standards | Mice, Inbred C57BL | Neurotransmitter Agents - metabolism | Male | Electrochemical Techniques - standards | Mice, 129 Strain | Organ Specificity | Adenosine - isolation & purification | Brain - metabolism | Adenosine Monophosphate - isolation & purification | Reference Standards | Animals | Adenosine Triphosphate - metabolism | Neurotransmitter Agents - isolation & purification | Adenosine - metabolism | Mice | Mice, Inbred BALB C | Adenosine Diphosphate - metabolism | Measurement | Purines | Brain | Nervous system diseases | Adenosine | Metabolites | Adenylic acid | Muscle proteins | High performance liquid chromatography | Adenosine triphosphate | Adenosine triphosphatase | Cerebellum | Cortex (olfactory) | Neurosciences | Animal models | Electrochemical analysis | Substance abuse treatment | Substantia nigra | Neurobiology | Parkinsons disease | Schizophrenia | ADP | Neuromodulation | Signal transduction | Rodents | Inbreeding | Neurological disorders | Caffeine | Dopamine | Adenosine monophosphate | AMP | Computational fluid dynamics | Adenosine diphosphate | Liquid chromatography | High-performance liquid chromatography | Signaling | Brain research | Electrochemistry | Olfactory bulb | ATP | Binding sites
A(2A) RECEPTORS | ELECTROCHEMICAL DETECTION | ANTAGONISTIC INTERACTION | NERVE-TERMINALS | BASAL GANGLIA | MULTIDISCIPLINARY SCIENCES | ACETYLCHOLINE-RELEASE | RAT-BRAIN | PARKINSONS-DISEASE | NUCLEUS-ACCUMBENS | INDUCED SEIZURES | Adenosine Diphosphate - isolation & purification | Adenosine Triphosphate - isolation & purification | Adenosine Monophosphate - metabolism | Chromatography, High Pressure Liquid - standards | Mice, Inbred C57BL | Neurotransmitter Agents - metabolism | Male | Electrochemical Techniques - standards | Mice, 129 Strain | Organ Specificity | Adenosine - isolation & purification | Brain - metabolism | Adenosine Monophosphate - isolation & purification | Reference Standards | Animals | Adenosine Triphosphate - metabolism | Neurotransmitter Agents - isolation & purification | Adenosine - metabolism | Mice | Mice, Inbred BALB C | Adenosine Diphosphate - metabolism | Measurement | Purines | Brain | Nervous system diseases | Adenosine | Metabolites | Adenylic acid | Muscle proteins | High performance liquid chromatography | Adenosine triphosphate | Adenosine triphosphatase | Cerebellum | Cortex (olfactory) | Neurosciences | Animal models | Electrochemical analysis | Substance abuse treatment | Substantia nigra | Neurobiology | Parkinsons disease | Schizophrenia | ADP | Neuromodulation | Signal transduction | Rodents | Inbreeding | Neurological disorders | Caffeine | Dopamine | Adenosine monophosphate | AMP | Computational fluid dynamics | Adenosine diphosphate | Liquid chromatography | High-performance liquid chromatography | Signaling | Brain research | Electrochemistry | Olfactory bulb | ATP | Binding sites
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 02/2009, Volume 106, Issue 8, p. 2933
 Oxidative stress has been implicated in the etiology of Parkinson's disease (PD) and in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) animal model...
Proteins | Antioxidants | Enzymes | Neurotoxicity | Rodents | Parkinsons disease | Gene expression | Binding sites
Proteins | Antioxidants | Enzymes | Neurotoxicity | Rodents | Parkinsons disease | Gene expression | Binding sites
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2012, Volume 7, Issue 5
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 08/2012, Volume 32, Issue 32, pp. 10887 - 10894
Midbrain dopaminergic (mDA) neurons control movement and emotion, and their degeneration leads to motor and cognitive defects in Parkinson's disease (PD)....
SURVIVAL | RNAS | MICRORNAS | DYSFUNCTION | EXPRESSION | NEUROSCIENCES | BRAIN | PARKINSONS-DISEASE | PITX3 | Tyrosine 3-Monooxygenase - metabolism | Mesencephalon - cytology | Age Factors | Cell Count | Homeodomain Proteins - metabolism | Dark Adaptation - genetics | Gene Expression Regulation, Developmental - genetics | Male | MicroRNAs - metabolism | Psychomotor Performance - physiology | Choline O-Acetyltransferase - metabolism | Mice, Neurologic Mutants | Exploratory Behavior - physiology | Chromatography, Liquid | Dopaminergic Neurons - physiology | Dopamine - metabolism | Animals, Newborn | Electrochemical Techniques | Maze Learning - physiology | Behavior, Animal - physiology | Mice, Knockout | Stereotaxic Techniques | Transcription Factors - metabolism | Motor Activity - genetics | Animals | Microdialysis | Analysis of Variance | Glutamate Decarboxylase - metabolism | Mesencephalon - growth & development | Mice | MicroRNAs - genetics
SURVIVAL | RNAS | MICRORNAS | DYSFUNCTION | EXPRESSION | NEUROSCIENCES | BRAIN | PARKINSONS-DISEASE | PITX3 | Tyrosine 3-Monooxygenase - metabolism | Mesencephalon - cytology | Age Factors | Cell Count | Homeodomain Proteins - metabolism | Dark Adaptation - genetics | Gene Expression Regulation, Developmental - genetics | Male | MicroRNAs - metabolism | Psychomotor Performance - physiology | Choline O-Acetyltransferase - metabolism | Mice, Neurologic Mutants | Exploratory Behavior - physiology | Chromatography, Liquid | Dopaminergic Neurons - physiology | Dopamine - metabolism | Animals, Newborn | Electrochemical Techniques | Maze Learning - physiology | Behavior, Animal - physiology | Mice, Knockout | Stereotaxic Techniques | Transcription Factors - metabolism | Motor Activity - genetics | Animals | Microdialysis | Analysis of Variance | Glutamate Decarboxylase - metabolism | Mesencephalon - growth & development | Mice | MicroRNAs - genetics
Journal Article
PloS one, 2012, Volume 7, Issue 3, p. e33693
Methylphenidate (MPH) is a psychostimulant that exerts its pharmacological effects via preferential blockade of the dopamine transporter (DAT) and the...
Microglia - cytology | Tumor Necrosis Factor-alpha - metabolism | Dopamine Plasma Membrane Transport Proteins - metabolism | Central Nervous System Stimulants - pharmacology | Vesicular Monoamine Transport Proteins - metabolism | Interleukin-6 - genetics | Microglia - drug effects | Oligonucleotide Array Sequence Analysis | Tumor Necrosis Factor-alpha - genetics | Basal Ganglia - metabolism | Glial Cell Line-Derived Neurotrophic Factor - genetics | Methylphenidate - pharmacology | Gene Expression Profiling | Substantia Nigra - metabolism | Dopamine Plasma Membrane Transport Proteins - genetics | Basal Ganglia - cytology | Dopaminergic Neurons - cytology | Glial Cell Line-Derived Neurotrophic Factor - metabolism | Animals | Vesicular Monoamine Transport Proteins - genetics | Dopaminergic Neurons - drug effects | Mice | Interleukin-6 - metabolism
Microglia - cytology | Tumor Necrosis Factor-alpha - metabolism | Dopamine Plasma Membrane Transport Proteins - metabolism | Central Nervous System Stimulants - pharmacology | Vesicular Monoamine Transport Proteins - metabolism | Interleukin-6 - genetics | Microglia - drug effects | Oligonucleotide Array Sequence Analysis | Tumor Necrosis Factor-alpha - genetics | Basal Ganglia - metabolism | Glial Cell Line-Derived Neurotrophic Factor - genetics | Methylphenidate - pharmacology | Gene Expression Profiling | Substantia Nigra - metabolism | Dopamine Plasma Membrane Transport Proteins - genetics | Basal Ganglia - cytology | Dopaminergic Neurons - cytology | Glial Cell Line-Derived Neurotrophic Factor - metabolism | Animals | Vesicular Monoamine Transport Proteins - genetics | Dopaminergic Neurons - drug effects | Mice | Interleukin-6 - metabolism
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 01/2010, Volume 19, Issue 9, pp. 1633 - 1650
Parkinson disease (PD) is a neurodegenerative disease with motor as well as non-motor signs in the gastrointestinal tract that include dysphagia,...
RODENT MODELS | WILD-TYPE | CONSTIPATION | INTESTINAL MOTILITY | HEART-RATE-VARIABILITY | GASTROINTESTINAL DYSFUNCTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | COLONIC TRANSIT | DOPAMINERGIC-NEURONS | BRAIN PATHOLOGY | LEWY BODIES | Immunohistochemistry | Motor Activity - physiology | Parkinson Disease - pathology | Age Factors | Humans | Central Nervous System - pathology | In Situ Hybridization, Fluorescence | Mice, Transgenic | DNA Primers - genetics | Chromatography, High Pressure Liquid | Parkinson Disease - genetics | Enteric Nervous System - abnormalities | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Rotarod Performance Test | Animals | Mutagenesis | Mice | alpha-Synuclein - genetics | alpha-Synuclein - metabolism | Dopamine - metabolism | Disease Models, Animal | Index Medicus
RODENT MODELS | WILD-TYPE | CONSTIPATION | INTESTINAL MOTILITY | HEART-RATE-VARIABILITY | GASTROINTESTINAL DYSFUNCTION | BIOCHEMISTRY & MOLECULAR BIOLOGY | GENETICS & HEREDITY | COLONIC TRANSIT | DOPAMINERGIC-NEURONS | BRAIN PATHOLOGY | LEWY BODIES | Immunohistochemistry | Motor Activity - physiology | Parkinson Disease - pathology | Age Factors | Humans | Central Nervous System - pathology | In Situ Hybridization, Fluorescence | Mice, Transgenic | DNA Primers - genetics | Chromatography, High Pressure Liquid | Parkinson Disease - genetics | Enteric Nervous System - abnormalities | Mutation - genetics | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Rotarod Performance Test | Animals | Mutagenesis | Mice | alpha-Synuclein - genetics | alpha-Synuclein - metabolism | Dopamine - metabolism | Disease Models, Animal | Index Medicus
Journal Article
International Journal of Neuroscience, ISSN 0020-7454, 2009, Volume 119, Issue 9, pp. 1362 - 1383
Dynorphin (DYN) fragments are the members of the endogenous opioid system and postulated ligands for the opioid receptors. Infusion of DYN1-17 fragment into...
dynorphin | acetylcholine | microdialysis | neurotransmitter | dopamine | HPLC-ED | Neurotransmitter | Acetylcholine | Dopamine | Microdialysis | Dynorphin | NEUROTRANSMITTER RELEASE | KAPPA-OPIOID RECEPTOR | STRIATONIGRAL DYNORPHIN | NEUROSCIENCES | NUCLEUS-ACCUMBENS | PEPTIDES | A 1-13 | REGULATORY ROLE | SUBSTANCE-P | MEDIATING PRESYNAPTIC INHIBITION | MODULATION | Brain Chemistry - drug effects | Microinjections | Peptide Fragments - administration & dosage | Rats | Male | Peptide Fragments - pharmacology | Acetylcholine - metabolism | Chromatography, High Pressure Liquid | Neostigmine - pharmacology | Rats, Sprague-Dawley | Neostriatum - physiology | Animals | Dynorphins - administration & dosage | Receptors, Presynaptic - drug effects | Cholinesterase Inhibitors - pharmacology | Electrochemistry | Synaptic Transmission - drug effects | Dynorphins - pharmacology | Neostriatum - anatomy & histology | Dopamine - metabolism
dynorphin | acetylcholine | microdialysis | neurotransmitter | dopamine | HPLC-ED | Neurotransmitter | Acetylcholine | Dopamine | Microdialysis | Dynorphin | NEUROTRANSMITTER RELEASE | KAPPA-OPIOID RECEPTOR | STRIATONIGRAL DYNORPHIN | NEUROSCIENCES | NUCLEUS-ACCUMBENS | PEPTIDES | A 1-13 | REGULATORY ROLE | SUBSTANCE-P | MEDIATING PRESYNAPTIC INHIBITION | MODULATION | Brain Chemistry - drug effects | Microinjections | Peptide Fragments - administration & dosage | Rats | Male | Peptide Fragments - pharmacology | Acetylcholine - metabolism | Chromatography, High Pressure Liquid | Neostigmine - pharmacology | Rats, Sprague-Dawley | Neostriatum - physiology | Animals | Dynorphins - administration & dosage | Receptors, Presynaptic - drug effects | Cholinesterase Inhibitors - pharmacology | Electrochemistry | Synaptic Transmission - drug effects | Dynorphins - pharmacology | Neostriatum - anatomy & histology | Dopamine - metabolism
Journal Article
Journal of Neuroscience, ISSN 0270-6474, 02/2012, Volume 32, Issue 5, pp. 1545 - 1559
The A/VN/1203/04 strain of the H5N1 influenza virus is capable of infecting the CNS of mice and inducing a number of neurodegenerative pathologies. Here, we...
EXPERIMENTAL PARKINSONS-DISEASE | DOPAMINERGIC NEURODEGENERATION | MONOCYTE CHEMOATTRACTANT | SYNUCLEIN ACTIVATES MICROGLIA | NEURONAL DEATH | CENTRAL-NERVOUS-SYSTEM | ALPHA-SYNUCLEIN | NIGRA PARS COMPACTA | SUBSTANTIA-NIGRA | NEUROSCIENCES | CELL-DEATH | Inflammation - pathology | Influenza, Human - metabolism | Influenza, Human - pathology | Humans | Mice, Inbred C57BL | Inflammation - virology | Brain - virology | Inflammation Mediators - adverse effects | Chick Embryo | Brain - metabolism | Central Nervous System Viral Diseases - virology | Animals | Central Nervous System Viral Diseases - metabolism | Inflammation Mediators - metabolism | Brain - pathology | Central Nervous System Viral Diseases - pathology | Female | Influenza A Virus, H5N1 Subtype - pathogenicity | Influenza, Human - virology | Mice
EXPERIMENTAL PARKINSONS-DISEASE | DOPAMINERGIC NEURODEGENERATION | MONOCYTE CHEMOATTRACTANT | SYNUCLEIN ACTIVATES MICROGLIA | NEURONAL DEATH | CENTRAL-NERVOUS-SYSTEM | ALPHA-SYNUCLEIN | NIGRA PARS COMPACTA | SUBSTANTIA-NIGRA | NEUROSCIENCES | CELL-DEATH | Inflammation - pathology | Influenza, Human - metabolism | Influenza, Human - pathology | Humans | Mice, Inbred C57BL | Inflammation - virology | Brain - virology | Inflammation Mediators - adverse effects | Chick Embryo | Brain - metabolism | Central Nervous System Viral Diseases - virology | Animals | Central Nervous System Viral Diseases - metabolism | Inflammation Mediators - metabolism | Brain - pathology | Central Nervous System Viral Diseases - pathology | Female | Influenza A Virus, H5N1 Subtype - pathogenicity | Influenza, Human - virology | Mice
Journal Article
Human Molecular Genetics, ISSN 0964-6906, 05/2010, Volume 19, Issue 9, pp. 1633 - 1650
Parkinson disease (PD) is a neurodegenerative disease with motor as well as non-motor signs in the gastrointestinal tract that include dysphagia,...
Journal Article
General and Comparative Endocrinology, ISSN 0016-6480, 04/2000, Volume 118, Issue 1, pp. 48 - 56
Catecholamines have previously been detected in numerous tissues and are thought to control a wide variety of physiological functions in bivalve molluscs. In...
spawn | bivalve | mollusc | dopamine | HPLC | reproduction | hormone | Hormone | Reproduction | Dopamine | Bivalve | Mollusc | Spawn | NERVOUS-SYSTEM | METABOLITES | NOREPINEPHRINE | MONOAMINES | BEHAVIOR | BIVALVE MOLLUSKS | NEUROTRANSMITTERS | ENDOCRINOLOGY & METABOLISM | SEROTONIN | PRECURSORS | Monoamine Oxidase Inhibitors - pharmacology | 3,4-Dihydroxyphenylacetic Acid - metabolism | Catecholamines - metabolism | Hemolymph - drug effects | Clorgyline - pharmacology | Selegiline - pharmacology | Hemolymph - metabolism | Male | Chromatography, High Pressure Liquid | Sexual Behavior, Animal - physiology | Dihydroxyphenylalanine - metabolism | Animals | Hemolymph - enzymology | Mollusca - metabolism | Pargyline - pharmacology | Female | Catechol O-Methyltransferase Inhibitors | Dopamine - metabolism
spawn | bivalve | mollusc | dopamine | HPLC | reproduction | hormone | Hormone | Reproduction | Dopamine | Bivalve | Mollusc | Spawn | NERVOUS-SYSTEM | METABOLITES | NOREPINEPHRINE | MONOAMINES | BEHAVIOR | BIVALVE MOLLUSKS | NEUROTRANSMITTERS | ENDOCRINOLOGY & METABOLISM | SEROTONIN | PRECURSORS | Monoamine Oxidase Inhibitors - pharmacology | 3,4-Dihydroxyphenylacetic Acid - metabolism | Catecholamines - metabolism | Hemolymph - drug effects | Clorgyline - pharmacology | Selegiline - pharmacology | Hemolymph - metabolism | Male | Chromatography, High Pressure Liquid | Sexual Behavior, Animal - physiology | Dihydroxyphenylalanine - metabolism | Animals | Hemolymph - enzymology | Mollusca - metabolism | Pargyline - pharmacology | Female | Catechol O-Methyltransferase Inhibitors | Dopamine - metabolism
Journal Article
Cellular and Molecular Neurobiology, ISSN 0272-4340, 1995, Volume 15, Issue 3, pp. 371 - 386
1. Although monoamines are well-known to play important roles in molluscan physiology, we are far from fully understanding the synthetic and degradative...
γ-glutamyl amine | catabolites | HPLC/ED | mollusk | monoamines | MONOAMINES | GAMMA-GLUTAMYL AMINE | HELIX-ASPERSA | MOLLUSK | MARINE BIVALVES | NEUROSCIENCES | CELL BIOLOGY | PERFORMANCE LIQUID-CHROMATOGRAPHY | PATINOPECTEN-YESSOENSIS | CATABOLITES | ELECTROCHEMICAL DETECTION | BIOGENIC-AMINES | DOPAMINE | APLYSIA-CALIFORNICA | CENTRAL-NERVOUS-SYSTEM | SEROTONIN | Catecholamines - metabolism | Indoles - analysis | Nervous System - metabolism | Biogenic Amines - analysis | Chromatography, High Pressure Liquid | Nervous System - chemistry | Mollusca - chemistry | Organ Specificity | Indoles - metabolism | Animals | Mollusca - metabolism | Catecholamines - analysis | Biogenic Amines - metabolism
γ-glutamyl amine | catabolites | HPLC/ED | mollusk | monoamines | MONOAMINES | GAMMA-GLUTAMYL AMINE | HELIX-ASPERSA | MOLLUSK | MARINE BIVALVES | NEUROSCIENCES | CELL BIOLOGY | PERFORMANCE LIQUID-CHROMATOGRAPHY | PATINOPECTEN-YESSOENSIS | CATABOLITES | ELECTROCHEMICAL DETECTION | BIOGENIC-AMINES | DOPAMINE | APLYSIA-CALIFORNICA | CENTRAL-NERVOUS-SYSTEM | SEROTONIN | Catecholamines - metabolism | Indoles - analysis | Nervous System - metabolism | Biogenic Amines - analysis | Chromatography, High Pressure Liquid | Nervous System - chemistry | Mollusca - chemistry | Organ Specificity | Indoles - metabolism | Animals | Mollusca - metabolism | Catecholamines - analysis | Biogenic Amines - metabolism
Journal Article
Neurochemistry International, ISSN 0197-0186, 1994, Volume 25, Issue 5, pp. 465 - 474
The biosynthesis of catecholamines and indoleamines was investigated in the sea pansy Renilla koellikeri by radiochemical screening of tissue samples exposed...
LOCALIZATION | COELENTERATE | METABOLISM | 5-HYDROXYTRYPTAMINE | NEUROTRANSMITTERS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CATECHOLAMINES | DOPAMINE | SEROTONIN | NEUROBIOLOGY | KOLLIKERI | NEUROSCIENCES | Biological Evolution | Cnidaria - metabolism | Indoles - metabolism | Animals | Catecholamines - metabolism | Tryptophan Hydroxylase - analysis | Phenylethanolamine N-Methyltransferase - analysis | Tyrosine 3-Monooxygenase - analysis
LOCALIZATION | COELENTERATE | METABOLISM | 5-HYDROXYTRYPTAMINE | NEUROTRANSMITTERS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CATECHOLAMINES | DOPAMINE | SEROTONIN | NEUROBIOLOGY | KOLLIKERI | NEUROSCIENCES | Biological Evolution | Cnidaria - metabolism | Indoles - metabolism | Animals | Catecholamines - metabolism | Tryptophan Hydroxylase - analysis | Phenylethanolamine N-Methyltransferase - analysis | Tyrosine 3-Monooxygenase - analysis
Journal Article
Invertebrate Reproduction & Development, ISSN 0792-4259, 07/1995, Volume 28, Issue 2, pp. 125 - 135
Serotonin (5-HT) was detected in various body tissues of the scallop using both immunocy-tochemistry and high performance liquid chromatography with...
monoaine | immunocytochemistry | Bivalves | indolamine | mollusc | HPLC | Immunocytochemistry | Mollusc | Indolamine | Monoaine
monoaine | immunocytochemistry | Bivalves | indolamine | mollusc | HPLC | Immunocytochemistry | Mollusc | Indolamine | Monoaine
Journal Article
12/2016
This invention relates is a label-free, enzyme-free, aptamer-free method for simultaneously measuring adenosine, and its intracellular metabolites, e.g., AMP,...
TRANSPORTING | HYGIENE | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES | MEDICAL OR VETERINARY SCIENCE | GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS | MEASURING | TECHNICAL SUBJECTS COVERED BY FORMER USPC | HUMAN NECESSITIES | PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL | GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC | TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS | TESTING | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | PHYSICS | SEPARATION | TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION | PERFORMING OPERATIONS
TRANSPORTING | HYGIENE | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES | MEDICAL OR VETERINARY SCIENCE | GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS | MEASURING | TECHNICAL SUBJECTS COVERED BY FORMER USPC | HUMAN NECESSITIES | PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL | GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC | TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS | TESTING | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | PHYSICS | SEPARATION | TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION | PERFORMING OPERATIONS
Patent
01/2016
This invention relates is a label-free, enzyme-free, aptamer-free method for simultaneously measuring adenosine, and its intracellular metabolites, e.g., AMP,...
TRANSPORTING | HYGIENE | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES | MEDICAL OR VETERINARY SCIENCE | GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS | MEASURING | TECHNICAL SUBJECTS COVERED BY FORMER USPC | HUMAN NECESSITIES | PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL | GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC | TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS | TESTING |
TRANSPORTING | HYGIENE | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES | MEDICAL OR VETERINARY SCIENCE | GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS | MEASURING | TECHNICAL SUBJECTS COVERED BY FORMER USPC | HUMAN NECESSITIES | PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL | GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC | TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS | TESTING |